Palestrante: Dr. Mucio Tavares de Oliveira Jr. - CRM: 47073-SP
| |
Palestrante: Dr. Otávio Rizzi Coelho Filho - CRM: 109063-SP
| |
Palestrante: Dra. Patricia Oliveira Guimarães - CRM: 141373-SP
| |
Palestrante: Dr. Thiago Quinaglia Araujo Costa Silva - CRM: 127490-SP
| |
Palestrante: Dr. Vagner Madrini Junior - CRM: 165004-SP
| |
Cooedenador/Debatedor: Dr. Dirceu Rodrigues de Almeida - CRM: 53852-SP
| |
Cooedenador/Debatedor: Dr. Marcelo Franken - CRM: 100733-SP
|
19h00 | Abertura - Dr. Marcelo Franken e Dr. Dirceu Rodrigues de Almeida |
19h05 | VESALIUS-CV – Effect of Evolocumab in Patients at High Cardiovascular Risk without Prior Myocardial Infarction or Stroke: Primary Results of the VESALIUS-CV trial |
19h15 | CORAMITUG: Primary results from a Phase 2 randomized, placebo-controlled, blinded trial of this monoclonal antibody in transthyretin amyloid cardiomyopathy (ATTR-CM). |
19h25 | ANSWER HF: A rnadomized Controled Trial of Sacubitril / Valsartana versus Enalapril in Patients with Chronic Chagas Cardiomyopathy and Reduced Ejection Fraction |
19h35 | SURPASS-CVOT – Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial) |
19h45 | NEO-MINDSET – Early Aspirin Withdrawl after Percutaneous Coronary Intervention in Acute Coronary Syndromes with and without ST Segment Elevation: Results from the NEO-MINDSET trial |
19h55 | perguntas e discussão - Dr. Marcelo Franken e Dr. Dirceu Rodrigues de Almeida |
20h30 | Encerramento |